Genetics; neuromuscular conditions; pediatric oncology; molecular diagnostics
Genetics, Hereditary Cancer, Hereditary Cancer Program
Detection of a novel gross deletion in the UNC13D gene ends the diagnostic odyssey for a family with familial hemophagocytic lymphohistiocytosis 3. BMC Pediatrics. 2024; 24:34.
Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome. American Journal of Medical Genetics, Part A. 2024; 194:e63788.
An evaluation of clinical presentation and genetic testing approaches for patients with neuromuscular disorders. American Journal of Medical Genetics, Part A. 2023; 191:2679-2692.
Comparison of genetic testing documentation between genetic counselors and non-genetic counselors. Journal of Genetic Counseling. 2023; 32:635-645.
Identification of Biallelic dystrophin gene variants during maternal carrier testing for Becker muscular dystrophy and review of the DMD exon 49-51 deletion phenotype. Molecular Genetics and Genomic Medicine. 2023; 11:e2088.
Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics. Journal of Genetic Counseling. 2021; 30:1559-1569.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey